Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Westervelt

Showing results (331-340 of 359) with videos related to

Pageof 36
Sort By:
The New England Journal of Medicine|March 16, 2012
Clonal architecture of secondary acute myeloid leukemiaMatthew J Walter, Dong Shen, Li Ding, et al.
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Leukemia|October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment responseMeagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
Cancer Discovery|August 23, 2020
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for LeukemiaMelissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2024
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational StudyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Myelodysplastic syndromes, version 2.2015Peter L Greenberg, Richard M Stone, Rafael Bejar, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)Joshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Blood|May 15, 2007
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropeniaDaniel C Link, Ghada Kunter, Yumi Kasai, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2023
An observation-based, reduced-form model for oxidation in the remote marine troposphereColleen B Baublitz, Arlene M Fiore, Sarah M Ludwig, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020Pamela Sue Becker, Elizabeth A Griffiths, Laura M Alwan, et al.
Pageof 36

Showing results (331-340 of 359) with videos related to

Sort By:
Pageof 36
The New England Journal of Medicine|March 16, 2012
Clonal architecture of secondary acute myeloid leukemiaMatthew J Walter, Dong Shen, Li Ding, et al.
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Leukemia|October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment responseMeagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
Cancer Discovery|August 23, 2020
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for LeukemiaMelissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2024
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational StudyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Myelodysplastic syndromes, version 2.2015Peter L Greenberg, Richard M Stone, Rafael Bejar, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)Joshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Blood|May 15, 2007
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropeniaDaniel C Link, Ghada Kunter, Yumi Kasai, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2023
An observation-based, reduced-form model for oxidation in the remote marine troposphereColleen B Baublitz, Arlene M Fiore, Sarah M Ludwig, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020Pamela Sue Becker, Elizabeth A Griffiths, Laura M Alwan, et al.
Pageof 36